Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Documents (9899)

Showing 12 of 9899 View All
Showing 726 of 825 pages

02b Consent Agenda Committee chairs and members terms Final pdf

1


Report to the
GAVI Alliance Board

Board -2013 -Mtg -1-Doc 02b
11 -12 June 2013
Subject : Consent A genda: C ommittee chairs and member terms :
Changes to By -Laws and Committee Charters
Report of: Debbie Adams, Managing Director, Law and Governance
Authored by: Kevin A. Klock, Head of Governance and Assistant Secretary
Agenda item: 02b
Category: For Decision
Strategic goal: Alliance operations
Section A Overview
1 Purpose of the report
1.1 Following the discussion at the November 2012 and 7 May 2013
Governance Committee meeting s, the Govenance Committee invite s the
Board to formally amend the governing documents to perform the
refreshment of committees every two years.
2 Recommendations
2.1 The Governa nc e Committee recommend s to the Board that it :
(a) Amend the second sentence of Article 4.2 of the By -Laws as follows:
? Each of the Board Committees shall have a presiding chair who
shall be one of the Board Members and shall be appointed annually
once every two years by the Board unless otherwise provided in the
Statutes, By -Laws or Charter of the relevant Committee .
(b) Amend the first sentence of Section 2 of the Charter of Executive
Committee as follows:
? Executive Committee members shall normally sit on the Executive
Committee for three two years and may be reappointed for a single
term, provided that an Eligible Organisation (or group of Eligible
Organisations) or Eligible Constituency shall be entitled, in
accordance with Article 10 of the Statutes, to have the same
person(s) serv e as its Excecutive Member(s) for such additional
time as it shall desire and shall be entitled to replace its member(s)
as it shall desire .

02e Consent Agenda Amendment to the Programme Funding Policy Final pdf

1


Report to the
GAVI Alliance Board

Board -2013 -Mtg -2-Doc 02e
11 -12 June 2013
Subject : Consent Agenda: Amendment to the Pro gramme
Funding Policy
Report of: Barry Greene, Managing Director, Finance & Operations
Authored by: Tony Dutson, Senior Director , Finance & CAO
Agenda item : 02e
Category: For Decision
Strategic goal : SG3 - Financing

Section A: Overview

1 Purpose of the repor t

1.1 This report highlights the changes to the Programme Funding Policy that are
required to reflect the removal of the GAVI Funding Affiliate (GFA) from the
IFFIm structure

2 Recommendations

2.1 The Audit and Finance Committee recommends that the Board :

Approve the amend ed GAVI Programme Funding Policy attached as A nnex 1
to Doc 02e .

3 Executive summary

3.1 In February 2013 The GAVI Fund Affilate was removed from the IFFIm
structure with the GFA Board electing to wind up the entity on 28 March 2013 .
3.2 The Programme Funding Policy is being updated to reflect the removal of the
GAVI Fund Affiliate (GFA) from the GAVI structure , following the decision of
the GFA Board on 28 March 2013 to wind -up that company . Remaining cash
and investment balances (approximately $109 million) held by GFA will be
transferred to the GAVI Alliance during 2013. Going forward IFFIm will
disburse funds directly to GAVI Alliance .
3.3 Annex 1 of the policy is also being updated to refer to ? new cash programmes?
instead of ?HSFP programmes ?, for consistency with current practice and
terminology .



03 CEO report pdf

1

Report to the
GAVI Alliance Board

Board -2013 -Mtg -1-Doc 03
11 -12 June 2013
Report of the Chief Executive Officer


4 June 2013
Dear Board Members,
Our meeting next week comes at a time when the vaccine landscape in the
developing world is changing faster than ever before, and during a record year for
growth in the Alliance?s programmes.
From 2000 until 2012, the Alliance funded around one billion doses of vaccine. This
year alone, we will fund over six hundred million doses. With Somalia?s introduction
of pentavalent vaccine in April, we are now supporting vaccine programmes in 72
count ries. We are also starting funding for our newest vaccines: in the last two
months the first GAVI -supported doses of human papilloma virus (HPV) vaccine was
used by Kenya in a demonstration programme, and Rwanda introduced measles -
rubella vaccine. Recen t announcements have shown that we are successfully
shaping vaccine markets. The tremendous attention that the new lower price for HPV
vaccine attracted gave further evidence of the strength of the Alliance and the
coalition working to tackle cancer and i mprove women and girls? health. In this record
year we are expecting to support 33 vaccine introductions into routine schedules, 14
campaigns, and seven HPV vaccine demonstration programmes. In addition to the
HPV and measles -rubella vaccine programmes, measles campaigns are also starting
this year. When the Alliance raised funds to sustain GAVI up to 2015, we were
aiming for the acceleration in vaccine introductions that we are now seeing. We are
having a massive impact on the health and well -being of millions of people.
After almost two years as CEO, I would like in this report to give you an overview of
the issues on the Board agenda, and some early thoughts on GAVI?s next phase.
First let me begin with an update on some of the exciting development s since the last
Board meeting.
The December meeting was followed by the Partners? Forum, which brought together
more than 6 50 leaders, experts and practitioners from across the vaccine world.
During the Forum, Tanzania simultaneously launched pneumococca l and rotavirus
vaccines. In an important example of south -to -south collaboration, Tanzanian
programme managers before the launch visited and studied the experience of
Ghana , which in April last year became the first country to launch the two vaccines
sim ultaneously. When I returned to Ghana in March this year , with Bill Gates, we
saw a country with a strong commitment to its primary healthcare system. What
particularly impressed us was the extent to which data was collected and used at all
levels to str engthen performance. There will be post -introduction evaluations in
Tanzania and Ghana later this year; in both countries the early signs are that the
introductions went well, with high levels of coverage being reported.

05 Financial forecast document Final pdf

1


Report to the
GAVI Alliance Board

Board -2013 -Mtg -2-Doc 05
11 -12 June 2013
Subject : Financial Forecast update
Report of: Barry Greene, Managing Director, Finance & Operations
Authored by: Tony Dutson, Senior Director, Finance & Chief Accounting
Officer
Agenda item : 05
Category: For Information
Strategic goal : Alliance operations

Section A: Overview
1. Purpose of the repor t
1.1 This report informs the Board of the updated GAVI financial forecast for 2011 -
2020 (Version 7.0F b1).
1.2 It also informs the Board of :
(a) Funds allotted through 30 April 2013 from the Programme Funding
Envelope amount that the Board approved in December 2012
(b) Programme disbursements made during 2012 and 2013 .
1.3 No programme approvals are being sought on this occasion.
2. Recommendations
2.1 This report is for information only.
3. Executive summary
3.1 Th e updated GAVI financial forecast (see Section B) incorporates the latest
demand estimates and funding decisions taken to date . The level of resources
reflects amounts pledged to date and an allowance for forecasting purposes
that direct contributions will continue at their 201 2-2014 level in subsequent
years.
3.2 The forecast indicates that through 2015, while GAVI will have sufficient
resources to cover the needs of existing programmes, additional resourc es of
US$ 221 million may be needed to fully meet estimated demand anticipated for
1 Version 7.0Fa of the Financial Forecast was shared with Audit & Finance Committee on 22 April
2013. That has been updated (as Version 7.0Fb) for this paper, to include programme funding
decisions taken through 30 April 2013, with an immaterial impact (of US$ 2 million) on the expenditure
forecast through 2015.

08 Chair s reflections on the day no paper pdf

1


Report to the
GAVI Alliance Board

Board -2013 -Mtg -1-Doc 06
11 -12 June 2013
Subject : Chair ?s reflections on the day
Agenda item : 08
No paper

09 Chair s overview no paper pdf

1


Report to the
GAVI Alliance Board

Board -2013 -Mtg -1-Doc 09
11 -12 June 2013
Subject : Chair ?s overview
Agenda item : 09
No paper

Subscribe to our newsletter